Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Depression Side Effect Labeling Awareness Act of 2019 This bill specifies that, if a drug's label indicates an increased risk of suicide or depression, this information must displayed prominently.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
Administrative law and regulatory proceduresConsumer affairsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Mental health
Depression Side Effect Labeling Awareness Act of 2019
USA116th CongressHR-4404| House
| Updated: 9/20/2019
Depression Side Effect Labeling Awareness Act of 2019 This bill specifies that, if a drug's label indicates an increased risk of suicide or depression, this information must displayed prominently.
Health Subcommittee, Energy and Commerce Committee
Health
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Administrative law and regulatory proceduresConsumer affairsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Mental health